Allergan Current Ratio 2006-2018 | AGN

Current and historical current ratio for Allergan (AGN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Allergan current ratio for the three months ending December 31, 2018 was 1.13.
Allergan Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $6.48B $5.73B 1.13
2018-09-30 $5.74B $6.23B 0.92
2018-06-30 $6.10B $6.13B 1.00
2018-03-31 $6.39B $5.82B 1.10
2017-12-31 $11.38B $9.85B 1.16
2017-09-30 $10.11B $8.56B 1.18
2017-06-30 $10.43B $8.64B 1.21
2017-03-31 $13.70B $10.39B 1.32
2016-12-31 $17.86B $7.88B 2.27
2016-09-30 $31.72B $8.03B 3.95
2016-06-30 $8.76B $8.87B 0.99
2016-03-31 $10.09B $10.20B 0.99
2015-12-31 $8.58B $8.29B 1.04
2015-09-30 $16.66B $8.13B 2.05
2015-06-30 $10.49B $7.65B 1.37
2015-03-31 $11.02B $7.66B 1.44
2014-12-31 $7.11B $5.25B 1.36
2014-09-30 $6.25B $4.48B 1.40
2014-06-30 $8.27B $4.18B 1.98
2014-03-31 $4.54B $3.00B 1.51
2013-12-31 $4.44B $3.30B 1.35
2013-09-30 $4.07B $2.81B 1.45
2013-06-30 $3.92B $2.39B 1.64
2013-03-31 $3.84B $2.94B 1.31
2012-12-31 $3.84B $2.75B 1.40
2012-09-30 $2.44B $1.56B 1.57
2012-06-30 $2.32B $1.53B 1.52
2012-03-31 $2.41B $1.58B 1.53
2011-12-31 $2.57B $1.84B 1.40
2011-09-30 $1.84B $1.02B 1.81
2011-06-30 $2.01B $1.37B 1.47
2011-03-31 $1.94B $0.86B 2.26
2010-12-31 $1.79B $0.81B 2.21
2010-09-30 $1.76B $0.75B 2.34
2010-06-30 $1.76B $0.75B 2.33
2010-03-31 $1.77B $0.88B 2.01
2009-12-31 $1.77B $1.05B 1.69
2009-09-30 $1.89B $0.44B 4.29
2009-06-30 $1.69B $1.19B 1.42
2009-03-31 $1.56B $1.14B 1.37
2008-12-31 $1.46B $0.48B 3.03
2008-09-30 $1.32B $0.40B 3.32
2008-06-30 $1.25B $0.43B 2.93
2008-03-31 $1.16B $0.44B 2.67
2007-12-31 $1.17B $0.45B 2.64
2007-09-30 $1.12B $0.40B 2.85
2007-06-30 $1.10B $0.46B 2.38
2007-03-31 $1.10B $0.45B 2.44
2006-12-31 $1.26B $0.69B 1.83
2006-09-30 $1.62B $0.35B 4.64
2006-06-30 $1.57B $0.38B 4.13
2006-03-31 $1.43B $0.31B 4.66
2005-12-31 $1.35B $0.25B 5.51
2005-09-30 $1.31B $0.25B 5.31
2005-06-30 $1.32B $0.24B 5.50
2005-03-31 $1.37B $0.24B 5.69
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $46.576B $15.787B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.460B 4.99
Mylan (MYL) United Kingdom $13.791B 5.84
Bausch Health Cos (BHC) Canada $8.063B 5.73
Dr Reddy's Laboratories (RDY) India $6.682B 26.65
Supernus Pharmaceuticals (SUPN) United States $1.834B 17.02
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.598B 2.60
Amphastar Pharmaceuticals (AMPH) United States $0.932B 86.61
Homology Medicines (FIXX) United States $0.855B 0.00
CymaBay Therapeutics (CBAY) United States $0.720B 0.00
Voyager Therapeutics (VYGR) United States $0.630B 0.00
Assembly Biosciences (ASMB) United States $0.411B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.411B 0.00
Akorn (AKRX) United States $0.367B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.176B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.173B 0.00
Sol-Gel Technologies (SLGL) Israel $0.135B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Agile Therapeutics (AGRX) United States $0.061B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Teligent (TLGT) United States $0.046B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.013B 0.00